JP2008538779A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008538779A5 JP2008538779A5 JP2008508135A JP2008508135A JP2008538779A5 JP 2008538779 A5 JP2008538779 A5 JP 2008538779A5 JP 2008508135 A JP2008508135 A JP 2008508135A JP 2008508135 A JP2008508135 A JP 2008508135A JP 2008538779 A5 JP2008538779 A5 JP 2008538779A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- compound
- unsubstituted
- acid addition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0508314.2A GB0508314D0 (en) | 2005-04-25 | 2005-04-25 | Organic compounds |
| PCT/EP2006/003768 WO2006114264A1 (en) | 2005-04-25 | 2006-04-24 | Acetylene derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008538779A JP2008538779A (ja) | 2008-11-06 |
| JP2008538779A5 true JP2008538779A5 (https=) | 2009-07-02 |
Family
ID=34640064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008508135A Pending JP2008538779A (ja) | 2005-04-25 | 2006-04-24 | アセチレン誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080194551A1 (https=) |
| EP (1) | EP1877367B1 (https=) |
| JP (1) | JP2008538779A (https=) |
| KR (1) | KR20080007334A (https=) |
| CN (1) | CN101163669A (https=) |
| AT (1) | ATE445593T1 (https=) |
| AU (1) | AU2006239549A1 (https=) |
| BR (1) | BRPI0609945A2 (https=) |
| CA (1) | CA2605267A1 (https=) |
| DE (1) | DE602006009789D1 (https=) |
| ES (1) | ES2335134T3 (https=) |
| GB (1) | GB0508314D0 (https=) |
| MX (1) | MX2007013226A (https=) |
| PL (1) | PL1877367T3 (https=) |
| PT (1) | PT1877367E (https=) |
| RU (1) | RU2007143509A (https=) |
| WO (1) | WO2006114264A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0220581D0 (en) * | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
| PE20060437A1 (es) * | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
| GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| GB0503646D0 (en) * | 2005-02-22 | 2005-03-30 | Novartis Ag | Organic compounds |
| GB0508319D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| GB0508318D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| GB0525672D0 (en) * | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| WO2011092290A1 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| EP2531490B1 (en) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
| KR20200087273A (ko) * | 2014-10-24 | 2020-07-20 | 란도스 바이오파마, 인크. | 란티오닌 합성효소 c-유사 2-계 치료제 |
| BR112020010983A2 (pt) | 2017-11-30 | 2020-11-17 | Landos Biopharma, Inc | método in vitro para gerar células preparadas a partir de células precursoras, células isoladas e método para tratar uma afecção em um animal com as células isoladas |
| BR112022002387A2 (pt) | 2019-12-20 | 2022-09-06 | Landos Biopharma Inc | Composto da fórmula z-y-q-y' ou um sal ou éster farmaceuticamente aceitável do mesmo |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3991064A (en) * | 1975-01-17 | 1976-11-09 | Warner-Lambert Company | Benzonaphthyridines |
| CA2156836A1 (en) * | 1993-03-18 | 1994-09-29 | Janusz Jozef Kulagowski | Benzimidazole derivatives |
| US5576336A (en) * | 1993-03-18 | 1996-11-19 | Merck Sharp & Dohme Limited | Indole derivatives as dopamine D4 antagonists |
| US5521297A (en) * | 1993-06-04 | 1996-05-28 | Salk Institute Biotechnology/Industrial Associates | Nucleic acids encoding human metabotropic glutamate receptors |
| WO1995029911A1 (en) * | 1994-04-28 | 1995-11-09 | Merck Sharp & Dohme Limited | Benzofuran derivatives as d4 receptor antagonists |
| US5830901A (en) * | 1994-08-10 | 1998-11-03 | Merch Sharp & Dohme Ltd | Tetrahydropyridinylmethyl derivatives of pyrrolo 2,3-B!pyridine |
| US5688798A (en) * | 1995-10-10 | 1997-11-18 | Hoffmann-La Roche Inc. | Pyrimidine compounds |
| AUPR201600A0 (en) * | 2000-12-11 | 2001-01-11 | Fujisawa Pharmaceutical Co., Ltd. | Quinazolinone derivative |
| GB0128996D0 (en) * | 2001-12-04 | 2002-01-23 | Novartis Ag | Organic compounds |
| US6806279B2 (en) * | 2001-12-17 | 2004-10-19 | Sunesis Pharmaceuticals, Inc. | Small-molecule inhibitors of interleukin-2 |
| US6995144B2 (en) * | 2002-03-14 | 2006-02-07 | Eisai Co., Ltd. | Nitrogen containing heterocyclic compounds and medicines containing the same |
| GB0503646D0 (en) * | 2005-02-22 | 2005-03-30 | Novartis Ag | Organic compounds |
| GB0508319D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| GB0508318D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
-
2005
- 2005-04-25 GB GBGB0508314.2A patent/GB0508314D0/en not_active Ceased
-
2006
- 2006-04-24 PL PL06724540T patent/PL1877367T3/pl unknown
- 2006-04-24 DE DE602006009789T patent/DE602006009789D1/de not_active Expired - Fee Related
- 2006-04-24 EP EP06724540A patent/EP1877367B1/en not_active Expired - Lifetime
- 2006-04-24 AU AU2006239549A patent/AU2006239549A1/en not_active Abandoned
- 2006-04-24 RU RU2007143509/04A patent/RU2007143509A/ru not_active Application Discontinuation
- 2006-04-24 BR BRPI0609945-9A patent/BRPI0609945A2/pt not_active IP Right Cessation
- 2006-04-24 CA CA002605267A patent/CA2605267A1/en not_active Abandoned
- 2006-04-24 MX MX2007013226A patent/MX2007013226A/es not_active Application Discontinuation
- 2006-04-24 US US11/912,622 patent/US20080194551A1/en not_active Abandoned
- 2006-04-24 JP JP2008508135A patent/JP2008538779A/ja active Pending
- 2006-04-24 WO PCT/EP2006/003768 patent/WO2006114264A1/en not_active Ceased
- 2006-04-24 ES ES06724540T patent/ES2335134T3/es not_active Expired - Lifetime
- 2006-04-24 CN CNA2006800136876A patent/CN101163669A/zh active Pending
- 2006-04-24 AT AT06724540T patent/ATE445593T1/de active
- 2006-04-24 KR KR1020077024434A patent/KR20080007334A/ko not_active Withdrawn
- 2006-04-24 PT PT06724540T patent/PT1877367E/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008538779A5 (https=) | ||
| JP2008538775A5 (https=) | ||
| US9255106B2 (en) | Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors | |
| JP6397488B2 (ja) | ＲＯＲγ調節因子 | |
| EP2253625B1 (en) | Pyridazinones, the preparation and the use thereof | |
| JP2010505930A5 (https=) | ||
| CN108727378A (zh) | 新型异喹啉类化合物及其医药用途 | |
| JP2008546731A5 (https=) | ||
| JP2014524476A5 (https=) | ||
| WO2015083750A1 (ja) | 神経新生に関する化合物及び医薬組成物 | |
| US11731985B2 (en) | Compositions and methods for treating cancer | |
| US20190092789A1 (en) | Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders | |
| PT1877365E (pt) | Derivados de acetileno | |
| WO2001021206A1 (en) | PREVENTIVES OR REMEDIES FOR MYOCARDITIS, DILATED CARDIOMYOPATHY AND CARDIAC INSUFFICIENCY CONTAINING NF-λB INHIBITORS AS THE ACTIVE INGREDIENT | |
| CN1268122A (zh) | 用作nos抑制剂的支化烷氧基取代的2－氨基吡啶 | |
| JP2007518767A5 (https=) | ||
| JP2014511865A (ja) | 水溶液中で多量化できるシリル単量体、およびその使用法 | |
| JP6542236B2 (ja) | 有機化合物 | |
| JPH11189586A (ja) | キノリン誘導体、イソキノリン誘導体、およびシンノリン誘導体、並びに抗炎症剤および抗アレルギー剤 | |
| JP2005517634A5 (https=) | ||
| CN115304603A (zh) | 喹唑啉类抑制剂的制备及其应用 | |
| US10093609B2 (en) | TAK1 kinase inhibitors, compositions, and uses related thereto | |
| WO2019065794A1 (ja) | Ｐａｃ１受容体拮抗薬を用いた鎮痛薬 | |
| EP3964509B1 (en) | Compound containing fused ring, use thereof and pharmaceutical composition containing same | |
| JP2019504827A (ja) | ポリヒドロキシ化ベンゾフェノンの組成物及び神経変性障害の処置方法 |